Disproportionality methods for pharmacovigilance in longitudinal observational databases

Statistical Methods in Medical Research

Volumn 22, Issue 1, 2013, Pages 39-56

  Zorych, Ivan ^a   Madigan, David ^a   Ryan, Patrick ^b   Bate, Andrew ^c  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b JOHNSON AND JOHNSON   (United States)

^c PFIZER INC   (United States)

Author keywords

data mining; disproportionality methods; EBGM; IC; longitudinal observational databases; OMOP; PRR; ROR; spontaneous report databases

Indexed keywords

ANALYTIC METHOD; ARTICLE; CHI SQUARE TEST; COMPUTER SYSTEM; DATA BASE; DATA MINING; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; HUMAN; LEARNING CURVE; LONGITUDINAL STUDY; MEASUREMENT ACCURACY; PATIENT INFORMATION; RANDOM SAMPLE; RISK; SPONTANEOUS REPORT SYSTEM;

ADULT; DATABASES, FACTUAL; DRUG THERAPY; HUMANS; LONGITUDINAL STUDIES; MALE;

EID: 84874500562     PISSN: 09622802     EISSN: 14770334     Source Type: Journal    
DOI: 10.1177/0962280211403602     Document Type: Article

References (37)

1. Hauben M, Madigan D, Gerrits CM, Walsh L, Van Puijenbroek EP. The role of data mining in pharmacovigilance. Expert Opin Drug Saf. 2005 ; 5: 929-948 (Pubitemid 41246142)
2. Praus M, Schindel F, Fescharek R, Schwarz S. Alert systems for post-marketing surveillance of adverse drug reactions. Stat Med. 1993 ; 12: 2382-2393
3. vanPuijenbroek EP, Egberts AC, Heerdink ER, Leufkens HG. Detecting drug-drug interactions using a database for spontaneous adverse drug reactions: an example with diuretics and non-steroidal anti-inflammatory drugs. Eur J Clin Pharmacol. 2000 ; 56: 733-738 (Pubitemid 32204498)
4. Orre R, Bate A, Norén GN, Swahn E, Arnborg S, Edwards IR. A Bayesian recurrent neural network for unsupervised pattern recognition in large incomplete data sets. Int J Neural Syst. 2005 ; 15: 207-222 (Pubitemid 44099502)
5. Mammadov MA, Rubinov AM, Yearwood J. The study of drug-reaction relationships using global optimization techniques. Optim Meth Software. 2007 ; 22: 99-126 (Pubitemid 44878961)
6. Caster O, Norén GN, Madigan D, Bate A. Large-scale regression-based pattern discovery: the example of screening the WHO global drug safety database. Stat Anal Data Min. 2010 ; 3 (4). 197-208
7. Bate A, Evans SJ. Quantitative signal detection using spontaneous ADR reporting. Pharmacoepidemiol Drug Saf. 2009 ; 18 (6). 427-436
8. Lieu TA, Kulldorff M, Davis RL, et al. Real-time vaccine safety surveillance for the early detection of adverse events. Med Care. 2007 ; 45: S89 - S95
9. McClure DL, Glanz JM, Xu S, Hambidge SJ, Mullooly JP, Baggs J. Comparison of epidemiologic methods for active surveillance of vaccine safety. Vaccine. 2008 ; 26: 3341-3345
10. Walker AM. Signal detection for vaccine side effects that have not been specified in advance. Pharmacoepidemiol Drug Saf. 2010 ; 19 (3). 311-317
11. Curtis JR, Cheng H, Delzell E, et al. Adaptation of Bayesian data mining algorithms to longitudinal claims data. Med Care. 2008 ; 46: 969-975
12. Jin H, Chen J, He H, Williams GJ, Kelman C, O'Keefe CM. Mining unexpected temporal associations: Applications in detecting adverse drug reactions. IEEE Trans Info Tech Biomed. 2008 ; 12: 488-500
13. Kulldorff M, Davis RL, Kolczak M, Lewis E, Lieu T, Platt R. A maximized sequential probability ratio test for drug and vaccine safety surveillance. Sequen Anal. 2008 ; 30: 58-78
14. Li L. A conditional sequential sampling procedure for drug safety surveillance. Stat Med. 2009 ; 28 (25). 3124-3138
15. Norén GN, Bate A, Hopstadius J, Star K, Edwards IR Temporal pattern discovery for trends and transient effects: its application to patient records. Proceedings of the 14th ACM SIGKDD International Conference on Knowledge Discovery and Data Mining -KDD 08. Las Vegas, Nevada, USA; 2008; pp. 963-971.
16. Schneeweiss S, Rassen JA, Glynn RJ, Avorn J, Mogun H, Brookhart MA. High-dimensional propensity scoring adjustment in studies of treatment effects using health care claims data. Epidemiology. 2009 ; 20: 512-522
17. Norén GN, Hopstadius J, Bate A, Star K, Edwards IR. Temporal pattern discovery in longitudinal electronic patient records. Data Min Knowl Discov. 2010 ; 20 (3). 361-387
18. Hocine MN, Musonda P, Andrews NJ, Farrington C. Sequential case series analysis for pharmacovigilance. J R Stat Soc: Series A (Stat Soc). 2009 ; 172 (1). 213-236
19. Davis RL, Kolczak M, Lewis E, et al. Active surveillance of vaccine safety data for early signal detection. Epidemiology. 2005 ; 16: 336-341 (Pubitemid 40590071)
20. Brown JS, Kulldorff M, Chan KA, et al. Early detection of adverse drug events within population-based health networks: application of sequential testing methods. Pharmacoepidemiol Drug Saf. 2007 ; 12: 1275-1284 (Pubitemid 350303439)
21. Brown JS, Kulldorff M, Petronis KR, et al. Early adverse drug event signal detection within population-based health networks using sequential methods: key methodologic considerations. Pharmacoepidemiol Drug Saf. 2009 ; 18 (3). 226-234
22. DuMouchel W. Bayesian data mining in large frequency tables, with an application to the FDA spontaneous reporting system. Am Stat. 1999 ; 53 (3). 170-190
23. DuMouchel W, Pregibon D Empirical Bayes screening for multi-item associations. Proceedings of the Seventh ACM SIGKDD. California: San Francisco ; 2001: 67-76.
24. Fram D, Almenoff J and DuMouchel W. Empirical Bayesian data mining for discovering patterns in post-marketing drug safety. Proceedings of the 9th ACM SIGKDD International Conference on Knowledge Discovery and Data Mining - KDD'03, Washington, DC, USA, 2003; pp. 359-368.
25. Evans SJ, Waller PC, Davis S. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf. 2001 ; 10 (6). 483-486 (Pubitemid 34100774)
26. Rothman KJ, Lanes S, Sacks ST. The reporting odds ratio and its advantages over the proportional reporting ratio. Pharmacoepidemiol Drug Saf. 2004 ; 13 (8). 519-523 (Pubitemid 39214028)
27. Bate A, Lindquist M, Edwards IR, et al. A Bayesian neural network method for adverse drug reaction signal generation. Eur J Clin Pharmacol. 1998 ; 54 (4). 315-321 (Pubitemid 28328016)
28. Norén NG, Bate A, Orre R, Edwards IR. Extending the methods used to screen the WHO drug safety database towards analysis of complex associations and improved accuracy for rare events. Stat Med. 2006 ; 25: 3740-3757 (Pubitemid 44613906)
29. Hauben M, Zhou X. A brief primer on automated signal detection quantitative methods in pharmacovigilance: focus on signal detection. Ann Pharmacother. 2003 ; 37 (7-8). 1117-1123
30. Hauben M, Reich L, Zhou X. Safety related drug-labelling changes: findings from two data mining algorithms. Drug Saf. 2004 ; 27 (10). 735-744 (Pubitemid 39158994)
31. Hauben M, Zhou X. Trimethoprim-induced hyperkalaemia - lessons in data mining. Br J Clin Pharmacol. 2004 ; 58 (3). 338-339 (Pubitemid 39209069)
32. van Puijenbroek EP, Bate A, Leufkens HGM, Lindquist M, Orre R, Egberts ACG. A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiol Drug Saf. 2002 ; 11: 3-10 (Pubitemid 34269590)
33. Hauben M, Reich L. Potential utility of data-mining algorithms for early detection of potentially fatal/disabling adverse drug reactions: a retrospective evaluation. J Clin Pharmacol. 2005 ; 45 (4). 378-384 (Pubitemid 40490411)
34. Madigan D, Vardi Y, Weissman I. Extreme value theory applied to document retrieval from large collections. Inform Retriev. 2006 ; 9: 273-294 (Pubitemid 43839175)
35. Madigan D. Discussion of Bayesian data mining in large frequency tables, with an application to the FDA spontaneous reporting system. Am Stat. 1999 ; 53 (3). 198-200
36. Finney DJ. Statistical logic in the monitoring of adverse reactions to therapeutic drugs. Meth Inform Med. 1971 ; 10: 237-242
37. Szarfman A, Machado SG, O'Neill RT. Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's spontaneous reports database. Drug Saf. 2002 ; 25 (6). 381-392 (Pubitemid 34729136)